Conclusions: Adopters of digital health activity trackers tend to be more adherent to hypertension, diabetes, and dyslipidemia medications, and adherence increases with tracking frequency. This suggests that there may be value in examining new ways to further promote medication adherence through programs that incentivize health tracking and leveraging insights derived from connected devices to improve health outcomes.
E-learning tools are now available for cardiovascular disease prevention, adult obesity, antimicrobial resistance, physical activity, social prescribing, giving children the best start in life and supporting those at risk of, or experiencing, homelessness.
A new rehabilitation programme which significantly improves the quality of life of patients with heart failure from the comfort of their own homes will be rolled out at four NHS centres across the UK.
How do you use information for your work and CPD? What do you think of MPFT library services? Tell us here and you could win £25 vouchers: https://www.surveymonkey.co.uk/r/B2JVNPR
This study raises the prospect of a possible new treatment to reduce LDL cholesterol for people who have not responded well to statins alone. Bempedoic acid has been shown to lower LDL cholesterol and appears safe over the course of 1 year.
To describe the type and the amount of formal and informal care received during the first year after home discharge and to identify the baseline predictors of the formal and informal care needs of stroke survivors.. To read the full article, log in using your NHS Athens details. To access full-text: click “Log in/Register” (top right hand side). Click ‘Institutional Login’ then select 'OpenAthens Federation', then ‘NHS England’. Enter your Athens details to view the article.
Young people in the UK are more likely to die from asthma or experience poor quality of life from long-term conditions than their counterparts in other high-income countries. To read the full article, log in using your MPFT NHS OpenAthens details.
Factors that influence the health of our blood vessels, such as smoking, high blood pressure, obesity and diabetes are linked to less healthy brains, according to new research part-funded by the MRC.
MRC-funded researchers led by the Universities of Leicester and Nottingham have discovered genetic differences that put some people at higher risk than others of developing chronic lung disease.
Assessing influence of anti-adalimumab (ADA) antibodies (AAA) on serum trough ADA levels and uveitis activity in long-term ADA treatment of juvenile idiopathic arthritis (JIA)-associated uveitis.. To read the full article, log in using your NHS OpenAthens details.
To undertake a theoretical systematic review to develop a conceptual model of illness‐related emotional distress in the context of symptom management in chronic respiratory disease.. To read the full article, log in using your NHS Athens details. To access full-text: click “Log in/Register” (top right hand side). Click ‘Institutional Login’ then select 'OpenAthens Federation', then ‘NHS England’. Enter your Athens details to view the article.
The NHS Long Term Plan includes a major ambition to prevent 150,000 strokes, heart attacks and vascular dementia cases over the next 10 years.
Improving the detection and treatment of the high-risk conditions atrial fibrillation, high blood pressure and high cholesterol has the potential to unlock considerable health gains.
People with long-term illness are just as likely to benefit from knee or hip surgery as those without. However, they are more likely to have complications following surgery and to be readmitted within three months.
Open access. Statin therapy has been shown to reduce major vascular events and vascular mortality in a wide range of individuals, but there is uncertainty about its efficacy and safety among older people. We undertook a meta-analysis of data from all large statin trials to compare the effects of statin therapy at different ages.
Statin therapy reduces major vascular events, such as heart attacks and strokes, in a wide range of people, including those over the age of 75, according to new research from MRC scientists.
For the new study, MRC scientists worked with Australian researchers to assess the effects of statins in nearly 187,000 people who had taken part in 28 large clinical trials. Participants were divided into six age groups from 55 to over 75 years old to assess the effects of statins on major vascular events, deaths and cancer incidence.
A statistically significant reduction in cardiovascular disease (CVD) and all-cause mortality was observed in participants aged 75-84 years with type 2 diabetes, but not in people without diabetes or older than this. NICE guidance and patient decision aids support shared decision-making between people and their health professional about whether to start taking a statin.
This guideline covers diagnosing and managing chronic obstructive pulmonary disease (COPD) in people aged 16 and older, which includes emphysema and chronic bronchitis. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer.